Mazor Robotics (NSDQ:MZOR) today reported third-quarter results that blew past the consensus forecast on Wall Street, more than doubling sales and paring its losses by more than 30%.
The Caesarea, Israel-based robot-assisted surgery company posted losses of -$3.7 million, or -7¢ per share, on sales of $17.2 million for the three months ended Sept. 30, cutting red ink by -30.1% on sales growth of 125.4% compared with Q3 2016.